These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10884374)

  • 1. FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model.
    Fukada J; Schena S; Tack I; Ruiz P; Kurimoto Y; Pang M; Aitouche A; Abe T; Striker LJ; Pham SM
    Circ Res; 2000 Jul; 87(1):66-72. PubMed ID: 10884374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide donor FK409 attenuates the development of neointimal hyperplasia in a rat aortic allograft model.
    Fukada J; Schena S; Tack I; Ruiz P; Kurimoto Y; Pang M; Aitouche A; Abe T; Striker LJ; Pham SM
    Transplant Proc; 2001; 33(1-2):536-7. PubMed ID: 11266945
    [No Abstract]   [Full Text] [Related]  

  • 3. FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty.
    Seki J; Nishio M; Kato Y; Motoyama Y; Yoshida K
    Atherosclerosis; 1995 Sep; 117(1):97-106. PubMed ID: 8546759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origin of neointimal smooth muscle cells in transplant arteriosclerosis from recipient bone-marrow cells in rat aortic allograft.
    Song Z; Li W; Zheng Q; Shang D; Shu X; Guan S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):303-6. PubMed ID: 17641848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-octanoyl Dopamine Attenuates the Development of Transplant Vasculopathy in Rat Aortic Allografts Via Smooth Muscle Cell Protective Mechanisms.
    Wedel J; Hottenrott MC; Bulthuis M; Huitema S; Yard BA; Hillebrands JL
    Transplantation; 2016 Jan; 100(1):80-90. PubMed ID: 26674731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aortic allograft vasculopathy by local delivery of platelet-derived growth factor receptor tyrosine-kinase blocker AG-1295.
    Karck M; Meliss R; Hestermann M; Mengel M; Pethig K; Levitzki A; Banai S; Golomb G; Fishbein I; Chorny M; Haverich A
    Transplantation; 2002 Nov; 74(9):1335-41. PubMed ID: 12451275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with the spontaneous nitric oxide releaser FK409 on vascular responses in established streptozotocin-induced diabetic rat.
    Kamata K; Hayashi T
    Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):275-94. PubMed ID: 10509739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
    Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
    J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Inhibition of Vanin Activity Attenuates Transplant Vasculopathy in Rat Aortic Allografts.
    Wedel J; Jansen PA; Botman PN; Rutjes FP; Schalkwijk J; Hillebrands JL
    Transplantation; 2016 Aug; 100(8):1656-66. PubMed ID: 27014792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency.
    Onuta G; van Ark J; Rienstra H; Boer MW; Klatter FA; Bruggeman CA; Zeebregts CJ; Rozing J; Hillebrands JL
    Atherosclerosis; 2010 Apr; 209(2):393-402. PubMed ID: 19913790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
    Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
    Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.
    Akyürek LM; Johnsson C; Lange D; Georgii-Hemming P; Larsson E; Fellström BC; Funa K; Tufveson G
    J Clin Invest; 1998 Jun; 101(12):2889-99. PubMed ID: 9637724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.
    Kita Y; Hirasawa Y; Maeda K; Nishio M; Yoshida K
    Eur J Pharmacol; 1994 May; 257(1-2):123-30. PubMed ID: 8082692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant mechanism of the new vasodilator, FK409.
    Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
    Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of novel nitric oxide donor (FK409) on pulmonary ischemia-reperfusion injury in rats.
    Takeyoshi I; Otani Y; Yoshinari D; Kawashima Y; Ohwada S; Matsumoto K; Morishita Y
    J Heart Lung Transplant; 2000 Feb; 19(2):185-92. PubMed ID: 10703696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone attenuates transplant arteriosclerosis after allogeneic aorta transplantation in rats.
    Onuta G; Rienstra H; de Boer JF; Boer MW; Roks AJ; Klatter FA; Uges DR; Navis G; Rozing J; Hillebrands JL
    Transplantation; 2007 Aug; 84(4):517-26. PubMed ID: 17713437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.
    Hillebrands JL; Klatter FA; van den Hurk BM; Popa ER; Nieuwenhuis P; Rozing J
    J Clin Invest; 2001 Jun; 107(11):1411-22. PubMed ID: 11390423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity.
    Yasa M; Kerry Z; Yetik G; Sevin G; Reel B; Ozdemir N; Erhan Y; Ustünes L; Berkan T; Ozer A
    Eur J Pharmacol; 1999 Jun; 374(1):33-9. PubMed ID: 10422638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seeding of recipient bone marrow cells reduces neointimal hyperplasia of de-endothelialized rat aortic allograft.
    Kitamura T; Sata M; Motomura N; Takamoto S
    Int Heart J; 2005 Mar; 46(2):303-12. PubMed ID: 15876813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.